Migraine drug helped mice cope with obesity.

An international team of researchers found that a drug used to treat migraine reduces appetite and promotes weight loss in mice with alimentary obesity. As it turned out, this effect is associated with an effect on serotonin 5-HT1B receptors in the arcuate (arcuate) nucleus of the hypothalamus.